Globus Medical Financial Ratios
GMED / Health Care|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Altman Z-Score 3.91 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
11.8%
Profit Margin
18.3%
Net Income / Revenue
Asset Turnover
0.55
Revenue / Total Assets
Equity Multiplier
1.16
Total Assets / Equity
Composite: 11.8% (reported: 11.8%)
Profitability
Liquidity
Current Ratio
4.26
Quick Ratio
2.74
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
0.55
Inventory Turnover
1.26
Days Sales Outstanding
84 days
As of FY2025 · SEC 10-K · Updated Jun 30, 2026
Earnings Quality
Accrual Ratio
-4.1%
+3.9pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.